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Abstract
Mycoplasma pneumoniae (Mp), a common cause of pneumonia, is associated with asthma; however, the mechanisms
underlying this association remain unclear. We investigated the cellular immune response to Mp in mice. Intranasal
inoculation with Mp elicited infiltration of the lungs with neutrophils, monocytes and macrophages. Systemic depletion of
macrophages, but not neutrophils, resulted in impaired clearance of Mp from the lungs. Accumulation and activation of
macrophages were decreased in the lungs of MyD88
2/2 mice and clearance of Mp was impaired, indicating that MyD88 is a
key signaling protein in the anti-Mp response. MyD88-dependent signaling was also required for the Mp-induced activation
of NFkB, which was essential for macrophages to eliminate the microbe in vitro. Thus, MyD88-NFkB signaling in
macrophages is essential for clearance of Mp from the lungs.
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Introduction
Asthma is a chronic inflammatory disease of the airways, driven
by Th2 lymphocytes and the type II cytokines IL-4, IL-5 and IL-
13. These signals lead to the recruitment of neutrophils,
monocytes, macrophages, lymphocytes, eosinophils and mast cells
into the lung tissue and airway lumen. Infiltration of these cells
into the lungs is associated with high-level production of airway
mucus and the development of airway hyper-reactivity [1].
Typical of most complex diseases, asthma susceptibility appears
to be multifactorial, including contributions by several genes and
multiple environmental factors. Genetic susceptibility involves
genes encoding functionally and structurally defined families of
molecules that are thought to determine risk of both atopy and
asthma. At least three groups of related genes have shown linkage
to asthma susceptibility: genes that govern innate immune
responses to environmental threats (CD14, TLR2, TLR4,
TLR6, NOD1 and NOD2); genes involved in differentiation
and activation of Th2 cells (IL-4, IL-13, IL-4R and GATA3); and
genes that activate a broad range of inflammatory functions
including recruitment of leukocytes to epithelial and endothelial
surfaces (TNF, LTa, CCL5, CCL24 and CCL26) [2].
In addition to genetic susceptibility, environmental factors,
including microbes, allergens and drugs, appear to contribute
either to the induction or to increased severity of existing asthma
[3]. One of the asthma-associated pathogens is Mycoplasma
pneumoniae (Mp) [4,5,6]. In 1998, Kraft and colleagues showed,
using PCR analysis of bronchoalveolar lavage (BAL) fluid, that
more than 40% of patients with chronic stable asthma, compared
to less than 10% of healthy control subjects, were positive for Mp
in their airways [7]. Antibiotic treatment reduced the severity of
asthma symptoms and improved pulmonary function in the subset
of asthmatic patients whose BAL fluids or endobronchial biopsies
were positive for Mp, whereas asthmatic patients who were Mp
negative showed no improvement with antibiotic treatment [8].
Although not all studies have detected a higher rate of recovery of
Mp from the airways of asthmatic subjects compared to controls
[9], these combined observations suggest that the presence of
microbes such as Mp in the airways may contribute to exacer-
bation of asthma symptoms in many populations.
Mycoplasmas are the smallest known self-replicating microor-
ganisms. They are primarily mucosal pathogens, residing extra-
cellularly in close association with epithelial surfaces. Mp is a
human pathogen that typically infects ciliated epithelial cells in the
respiratory tract, producing upper and lower airway infection [10].
Because Mp lacks all of the genes involved in amino acid synthesis,
it is dependent on an exogenous supply of amino acids from its
environment. Thus, Mp depends on a close association with host
cells for its survival. The importance of this close association is
underscored by the essential role of the Mp attachment organelle
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leading end of the bacterium, mediates close physical interactions
between Mp and host epithelial cells. The attachment organelle of
Mp is also essential for cell division and gliding motility [11]. The
P1 and P30 adhesins, two critical components of this attachment
organelle, play fundamental roles in the interactions of Mp with
host airway epithelial cells and are required for virulence
[10,12,13,14].
Pattern recognition receptors (PRR) are essential for innate
immunity to invading pathogens. One of the best-characterized
groups of PRR is the family of Toll-like receptors (TLR). Signal
transduction in the TLR pathways is mediated by four activating
adaptors, including myeloid differentiation factor 88 (MyD88),
TIR domain-containing adaptor protein (TIRAP, also called
MyD88 adaptor-like (MAL)), TIR domain-containing adaptor
inducing interferon-b (TRIF, also known as toll-IL-1 receptor
adaptor molecule 1 (TICAM-1)), and TRIF-related adaptor
molecule (TRAM, also named toll-like receptor adaptor molecule
2 (TICAM-2)) [15,16]. MyD88 serves as the major adaptor
molecule for all TLRs, except TLR3. TLR signals transduced
through MyD88 ultimately activate NFkB and several of the
interferon regulatory factors, all of which are transcription factors
that regulate the expression of downstream genes required for
TLR-induced cell activation. These downstream genes encode
MHC molecules, T cell costimulatory molecules, cytokines,
chemokines and their receptors, and many other activation
associated genes [15,17], which are critical for immune cells to
respond to and eliminate invading pathogens.
Recent studies using experimental infection of mice have shown
that IL-12 modulates the host response to Mp [18] and have
established that signaling by TLR2 is required for the normal
increased production of mucus by Mp-challenged airway epithelial
cells [18,19]. Nevertheless, the cellular mechanisms used by the
host to control Mp in vivo remain largely undefined.
For this study, we developed a sensitive, specific and rapid
method to detect Mp quantitatively in mouse lungs by using real-
time PCR and verified that this assay detected similar numbers of
Mp in the lungs of experimentally infected mice compared to
quantitation by colony count of Mp recovered from minced lung
tissue. Using this method, we focused on the cellular and
molecular mechanisms used by the host to clear Mp from the
lungs in an experimental mouse model. We show that macro-
phages, but not neutrophils, play a critical role in clearance of Mp
from the lungs of mice. Additionally, we demonstrate an essential
role for MyD88-NFkB signaling in the macrophage response to
Mp in vivo and in vitro. This signaling pathway is required both for
activation of macrophages in the lungs and for elimination of Mp
both from the airways and from cultures of bone marrow-derived
macrophages.
Results
Quantitative detection of Mp in the lungs of mice
Mp can be cultured on SP4 agar, but replicates slowly. Because
of its lack of a cell wall and limited capacity to synthesize many
important biomolecules, Mp is very sensitive to changes in its
microenvironment. In addition, recent studies suggest that Mp
may be a facultative intracellular pathogen, from which compart-
ment it may be difficult to culture or affect with certain classes of
antibiotics [20]. To quantify Mp rapidly from infected tissues, we
developed a real-time PCR-based method for measuring the
numbers of Mp in extracts of mouse lung.
For the real-time PCR assay we targeted the Mp 16S rRNA,
because portions of this RNA are unique for each of the known
mycoplasma strains and because the RNA is present in high copy
number in the microbe. The assay is focused on the variable 59
end region of the Mp 16S rRNA. This portion of the Mp 16S
rRNA gene has been used as a target for a DNA-based semi-
quantitative PCR assay in the past [21], but not using the RNA-
based real-time PCR technology. We used the murine housekeep-
ing gene, GAPDH, as an internal control for normalization of the
amount of lung tissue represented in each RNA preparation.
In order to generate a standard curve for numbers of Mp, total
RNA was purified from the lungs of one non-infected mouse, and
RNA from the indicated numbers (1 to 10
8)o fMp was added.
100 ng of total RNA was used for each real-time PCR reaction.
Over a range of ,10
2 to 10
8 mycoplasmas per lung, this assay
showed a linear relationship between the numbers of Mp (x-axis,
log10) and the threshold number of cycles (y-axis, Ct) (Figure 1).
Thus, this assay provides a detection sensitivity of ,100 Mp in the
lungs of an individual mouse. In order to assess the degree to
which real-time PCR and bacterial culture with colony count yield
comparable data, we analyzed Mp numbers in the lungs of mice
using both techniques in the same experiment. Our data showed
that real-time PCR and conventional culture and colony count
provided very similar numbers of Mp in the lungs of infected mice
at d1, d3, and d5 after inoculation with Mp (Figure S1). Because
the real-time PCR assay is more rapid and equally sensitive
compared to bacterial culture, we have used it for the remainder of
our studies.
Time course for the clearance of Mp from the lungs of
C57BL6 and BALB/c mice
Mice were inoculated i.n. with 4610
6 Mp on d0, and were
sacrificed 2 h, 1 d, 3 d, 7 d, 2 wk, and 4 wk later. Based on an
analysis of the numbers of Mp using the real-time PCR assay, Mp
were cleared from the lungs of C57BL/6 mice within 7 days post-
inoculation (Figure 2A); in BALB/c mice, the clearance of Mp
from the lungs was reproducibly slower, reaching numbers below
the level of detection of the assay by 4 weeks indicating that there
are genetic background effects on Mp clearance (Figure 2B). To
eliminate this type of variability, for the remainder of our study we
used C57BL/6 as the wild type (WT) mouse strain. Importantly, in
both strains of mice, 90% or more of the Mp were eliminated from
the lungs over the first day (Figures 2A and 2B). This rapid, early
clearance of Mp suggested that innate host responses play a major
role in the elimination of Mp from the lungs of mice. We tested the
Figure 1. Quantitative detection of Mp in mouse lung by real-
time PCR. A portion of the 16S rRNA (from nucleotides 201 to 265) that
is specific for Mp was chosen as the molecular target for detection. Total
RNA was purified from the lungs of one mouse, and RNA from the
indicated number of Mp was added. 100 ng of total RNA was used for
each real-time PCR reaction. Ct, cycle threshold. The sensitivity and
linearity of the assay were confirmed in one additional experiment. Data
shown are means 6 SEM.
doi:10.1371/journal.pone.0014417.g001
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from 4610
5 to 4610
7 cfu/animal. At days 2 and 3 after
inoculation, the numbers of Mp recovered from the lungs were
in proportion to the infectious dose, indicating that the ability of
these innate responses to handle the bacterial load were not
saturated at this level of challenge (data not shown).
Consistent with this, there were no significant differences in the
rate of clearance of Mp from the lungs of WT mice and Rag1
2/2
mice, which lack T and B lymphocyte-based adaptive immune
responses [22] (Figure S2). These data support the central
importance of the innate immune response in the elimination of
Mp from the lungs of mice.
Rapid recruitment of neutrophils and macrophages/
monocytes to the mouse lung following inoculation with
Mp
To investigate the role of innate cells in the clearance of Mp,w e
first determined the nature of the host’s cellular inflammatory
response following airway inoculation with the microbe. Leuko-
Figure 2. Host responses to Mp. Mice were inoculated intranasally with 4610
6 Mp. At the indicated times, total lung RNA was harvested and the
numbers of Mp were measured by real-time PCR. Time course of Mp clearance from lungs of C57BL/6 mice (A) and BALB/c mice (B). For examining the
cellular host response to respiratory Mp, whole lungs were digested into single cell suspensions and stained with Abs for FACS analysis. (C) At 6 h and
24 h after infection with Mp, CD11b
+Gr-1
hi and CD11b
+Gr-1
lo/2 cell populations were recruited in the lungs. (D) Within the CD11b
+Gr-1
hi population
of cells analyzed 24 h post-Mp infection, the major cell types were neutrophils (CD11c
2F4/80
2) and a small subset of pulmonary macro-
phages (CD11c
+F4/80
+). (E) The CD11b
+Gr-1
lo/2 cell population includes pulmonary macrophages (CD11c
+F4/80
+), macrophage/monocytes
(CD11c
2F4/80
lo/2) and DC (CD11c
+F4/80
2 ). Each experiment was replicated at least two times. Data shown are means 6 SEM (n=6).
doi:10.1371/journal.pone.0014417.g002
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animals consist both of resident populations of innate cells and
additional cells recruited from the periphery in response to the
potential pathogen. The resident cell populations include macro-
phages, monocytes, dendritic cells (DC), NK cells, mast cells,
neutrophils and other granulocytes, all cell types that can respond
to invading pathogens.
Following i.n. inoculation with Mp, there was a rapid
and substantial increase in the numbers of CD11b
+ cells in the
lungs (Figure 2C). Based on their staining with anti-Gr-1, these
CD11b
+ cells comprised two subpopulations, CD11b
+Gr-1
hi and
CD11b
+Gr-1
lo/2. By 6 hr, the CD11b
+Gr-1
hi cells were dramat-
ically increased from ,5% of total lung leukocytes to .20% of
total lung leukocytes. This population remained elevated at .10%
of total lung cells at 24 h after inoculation with Mp (Figure 2C).
The CD11b
+Gr-1
lo/2 cells were increased from 10.5% of total
lung cells in control animals to 13% of total cells 6 hr after
inoculation with Mp, and to .20% by 24 h after microbial
challenge (Figure 2C). The numbers of both of these two cell
populations had returned to the baseline by 2–4 days after
inoculation with Mp (data not shown).
Each of these CD11b
+ cell populations could be further
fractionated based on their surface expression of F4/80 (typically
expressed on macrophages) and CD11c (typically expressed on
DC and pulmonary macrophages). The largest cellular subpop-
ulation, representing approximately 80–90% of the cells in the
CD11b
+Gr-1
hi gate, did not stain with antibodies to CD11c or
F4/80 (Figure 2D), and expressed Ly6G, but not Ly6C (data not
shown). Based on this pattern of cell surface marker expression,
this subset has phenotypic characteristics typical of neutrophils
[23]. A minority subpopulation in the CD11b
+Gr-1
hi gate
expressed CD11c and F4/80 (Figure 2D), typical of pulmonary
macrophages [24].
Analysis of cells within the CD11b
+Gr-1
lo/2 gate for expression
of CD11c and F4/80 discriminated three subpopulations
(Figure 2E). Cells that were CD11b
+Gr-1
lo/2CD11c
2F4/80
lo/2
were monocytes/macrophages, whereas cells that were CD11b
+Gr-
1
lo/2CD11c
+F4/80
+ were activated pulmonary macrophages. The
minority subpopulation that was CD11b
+Gr-1
lo/2 CD11c
+F4/80
2
consisted primarily of myeloid-type DC [25,26,27].
Altogether, these data demonstrated that both neutrophils
(CD11b
+Gr-1
hiCD11c
2F4/80
2) and monocytes/macrophages
(CD11b
+Gr-1
lo/2CD11c
+/2F4/80
+/lo or CD11b
+Gr-1
hiCD11c
+F4/
80
+) were recruited into the lungs within the first 24 h after i.n.
instillation of Mp, during the period when 90% or more of the bacteria
were cleared from the lungs (Figures 1, 2C, 2D, and 2E).
Clearance of Mp from the airways of mice is insensitive to
depletion of neutrophils
Because neutrophils were recruited rapidly and in high numbers
into the lungs of mice following i.n. inoculation with Mp
(Figures 2C and 2D), we tested whether this cell population
contributed to the clearance of the organism from the lungs. We
induced systemic depletion of neutrophils by treatment of adult
WT mice with i.v. injection of 100 mg of an anti-Gr-1 mAb (clone
RB6-8C5) prior to i.n. inoculation with Mp. Two days after
injection with RB6-8C5, the depletion of CD11b
+Gr-1
hi cells in
both the blood and the lungs was greater than 99% [28]. There
was no significant depletion of Gr-1
lo populations in either blood
or lungs [28]. One day after inoculation with Mp, depletion of
neutrophils remained at a high level in the anti-Gr-1 Ab-treated
mice, with only 10% as many lung neutrophils as observed in
microbe challenged mice that had received the control mAb
(Figure 3A).
Neutrophil-depleted mice cleared Mp from their lungs at a rate
equal to or modestly faster than mice treated with the control Ab
(Figure 3B). In order to confirm that neutrophils are not essential
for the clearance of Mp from the lungs, we tested CD11b
2/2 mice,
which have morphologically abnormal neutrophils, and impaired
neutrophil recruitment, activation, and apoptosis [29,30]. As with
mice treated with the RB6-8C5 mAb, we found no difference in
the clearance of Mp from lungs of CD11b
2/2 mice compared to
WT control animals (Figure S3). Together, these data indicate that
neutrophils do not play an essential role for elimination of Mp from
the lungs of naı ¨ve mice.
Systemic depletion of macrophages impairs the
elimination of Mp from the lungs
To test the role of macrophages in the host responses to Mp,w e
depleted macrophages systemically by injection of clodronate-
containing liposomes both i.p. and i.n. Injection of clodronate
liposomes by both the i.n. and the i.p. routes was required to obtain
effective depletion of both resident pulmonary (CD11c
hiCD11b
lo)
and recruited and interstitial (CD11c
loCD11b
hi) monocyte/macro-
phages following microbial challenge (Figure S4). One day after
liposome injection, mice were inoculated i.n. with Mp. In animals
that had been treated with the control liposomes, the percentage of
CD11b
+CD11c
+ cells (mainly activated resident macrophages and
recruited monocyte/macrophages, and a small subset of DC) was
9.76%. This cell population was substantially reduced (to ,2.5%) in
the lungs of mice that had been treated with clodronate liposomes
prior to i.n. challenge with Mp (Figure 4A). This greater than 70%
depletion in lung macrophages was associated with impaired
clearance of Mp from the lungs. Numbers of Mp were not
significantly different at days 2 and 3 after i.n. microbial challenge;
however, at d 5 and d 7 after inoculation, there were several
hundred-fold more Mp in the lungs of the clodronate liposome-
treated mice compared to mice treated with the control liposomes
(Figure 4B). These data show that, while macrophages are not
essential for the initial elimination of Mp from lungs of mice
observed in the first 3 days after microbial challenge of the airway,
macrophages are essential for the final elimination of the microbe
after d 3. Interestingly, varying the inoculating dose of Mp over a
100-fold range did not alter the ability of WT mice to clear the
bacteria by d 5 (data not shown), suggesting that the ability of the
respiratory tract macrophages to clear Mp remaining at these late
time points is relatively independent of the initial bacterial load.
To confirm the importance of macrophages in the clearance of
Mp, we also tested clearance from the lungs of Csf1
op/op mice,
which manifest reduced numbers of macrophages and monocytes
[31] because of a mutation in CSF1 (also designated M-CSF). The
numbers of Mp recovered from the lungs of Csf1
op/op mice at 3 d
after i.n. inoculation were not statistically different from the
numbers recovered from control mice (either Csf1
op/+ or Csf1
+/+
mice) (Figure 4C); however, at d 5 and d 7 post-inoculation, there
were10-to 100-foldgreaternumbers ofMp inthelungs ofCsf1
op/op
mice compared to control animals (Figure 4C). Thus, when the
numbers of host macrophages are reduced either due to a
congenital deficiency in the production of these cells (CSF1
op/op
mice) or by depletion using clodronate liposomes, then the terminal
phase of elimination of Mp is impaired.
Phagocytosis of Mp in vitro by macrophages
Having established the importance of macrophages in the
elimination of Mp from the lungs and airways, we next investigated
how macrophages respond when cultured with the microbe in vitro.
In order to visualize the encounter of macrophages with the
microbe, we co-cultured Mp with adherent bone marrow-derived
Innate Clearance of Mycoplasma
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washed the adherent cells with PBS, and analyzed the cells by
transmission electron microscopy. Cells cultured with Mp showed
large clusters of the microbe in phagocytic vacuoles (Figure 5A,
upper arrow) as well as clusters of bacteria apparently in the early
phases of cellular uptake (Figure 5A, lower arrow). To analyze the
role of phagocytosis in greater detail, we stained the cells with
reagents specific for endosomes or lysosomes and with the
LysoTracker dye, then analyzed the cells by fluorescence
microscopy. To test for phagosome-endosome fusion, we pre-
loaded the endosomes of BMM with fluorophore-conjugated
dextran [32] and then incubated with Mp carrying a gene
encoding enhanced yellow fluorescent protein (EYFP-Mp; see
Materials and Methods) for 1 hr (Figure 5B). This experiment
demonstrated co-localization of dextran with the majority of Mp-
containing cell organelles, indicating that phagosome-endosome
fusion had occurred.
To further examine the process of phagosome maturation, we
stained the cells with the lysosome-specific marker LAMP-2
(Figure 5C). The addition of Mp to the cultured cells resulted in
enhanced localization of LAMP-2 in close approximation to
vacuoles that contained abundant Mp, showing the localization of
Mp with a phago-lysosomal compartment. To investigate whether
the Mp-containing vesicles were acidified, we cultured BMM with
EYFP-Mp and then stained the cells with LysoTracker Red, an
indicator of phagolysosome acidification (Figure 5D). Addition of
Figure 3. Neutrophils are not required for clearance of Mp from mouse lung. (A) Greater than 90% of the CD11b
+Gr-1
hi cells (mainly
neutrophils) in mouse lung were depleted by i.v. injection with anti-Gr-1 Ab (RB6-8C5) with or without Mp infection. Data shown were collected 3 d
after injection of the anti-Gr-1 Ab, and 1 d after inoculation i.n. with Mp. (B) Neutrophil depleted mice (filled bars) showed no significant difference in
clearance of Mp from the lungs at all indicated times post-Mp inoculation, compared to control mice (open bars). At least three similar experiments
were performed with comparable results. Data shown are means 6 SEM (n=4 or 5). P.0.05, comparing control and Gr-1 Ab injected mice at each of
the time points.
doi:10.1371/journal.pone.0014417.g003
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LysoTracker-dependent staining of phagolysosomal vacuoles, with
co-localization of the intracellular Mp and the acid indicator dye.
Thus, as early as 1 h after infection, Mp had been taken up by
macrophages into a phagosomal compartment that fused with
lysosomal elements to form an acidified phagolysosome.
Cellular adhesive interaction is required for persistence of
Mp in the murine respiratory tract but not for
macrophage-dependent Mp clearance
To understand further the molecular mechanisms by which
macrophages recognize invading Mp, we tested the importance of
adhesive interactions for clearance of the microbe. The myco-
plasmal P1 adhesin is an essential component of the mycoplasma
attachment organelle by which the microbe adheres to the surface
of host epithelial cells in the respiratory tract [12]. P1-deficient Mp
loses its ability to attach to the host airway epithelium and
expresses greatly reduced virulence [33]. This is manifested by
accelerated clearance of P1-deficient Mp from the respiratory tract
of WT mice (Figure S5). To test whether macrophages are
required for clearance of P1-deficient Mp, we inoculated
macrophage-depleted mice with P1-deficient Mp and determined
the numbers of Mp present in the lungs at various subsequent time
points. Depletion of macrophages resulted in prolongation of the
persistence of the P1-deficient Mp, but they were still cleared more
Figure 4. Macrophages play an essential role in the elimination of Mp from the lungs of mice. (A) Greater than 70% of the pool of
CD11c
+CD11b
+ cells (mainly macrophages) in the lungs of Mp-challenged mice was depleted by injection (i.p. + i.n.) with clodronate-containing
liposomes (3 d after injection with liposomes, 1 d after inoculation with Mp). (B) and (C) Macrophage-depleted mice (filled bars) (B) and CSF1
op/op
mice (filled bars) (C) showed impaired clearance of Mp from the lungs at the indicated times post-Mp inoculation, compared to control mice (open
bars). For clodronate depletion of macrophages, at least 5 experiments were performed with similar results. For CSF1
op/op mice, the experiment was
repeated once with similar results. Data shown are means 6 SEM (n=3 or 5). * p,0.05.
doi:10.1371/journal.pone.0014417.g004
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between Mp and the responding macrophage are not required for
macrophage-dependent clearance of the microbe from the lungs
and airways. These data suggest that, while P1-dependent Mp-host
cell interactions contribute importantly to the ability of the
microbe to persist in the respiratory tract, non-P1-dependent
mechanisms are central to the interactions of Mp with host
macrophages. We hypothesized, consequently, that macrophage
PRR might contribute importantly to this response.
Signaling through the adaptor protein MyD88 is essential
for the macrophage response to Mp in the lungs
The TLR family is one of the best-characterized families of
PRR. It has been shown to play a key role in the triggering of both
the innate and the adaptive arms of the immune response [15],
and serves as a bridge between innate and adaptive immunity
[34,35,36]. MyD88 is the major adaptor molecule for signal-
ing downstream of TLR [37]. Therefore, we tested the role of
TLR-MyD88 signaling in the clearance of Mp from the lungs of
mice.
Three days after inoculation with 4610
6 Mp, there were 10
5 Mp
remaining in the lungs of MyD88
2/2 mice, compared to 10
3 Mp
in lungs of WT mice (Figure 6A). Seven days and 14 days after
inoculation with Mp, the microbe was undetectable in the lungs of
WT mice; in contrast, 10
2-10
3 Mp were detected in the lungs of
MyD88
2/2 mice (Figure 6A). This significant impairment in the
elimination of Mp from the lungs of MyD88
2/2 mice indicates
that the signaling adaptor MyD88 is essential for the elimination of
Figure 5. Macrophage phagocytosis of Mp in vitro. (A) BMM were infected with Mp for 1 h, and the cells were fixed with 2% paraformaldehyde
and 2% glutaraldehyde prior to embedding for TEM. Internalized Mp are highlighted by the black arrows. BMM were pre-loaded with dextran to label
endosomes (B), and stained with anti-LAMP-2 antibody to visualize lysosomes (C) or LysoTracker dye to visualize acidified compartments (D). (B-D)
cultures were infected with Mp (MOI 100:1) or mock infected with medium alone as indicated. All portions of these experiments were repeated at
least two times, always with similar results.
doi:10.1371/journal.pone.0014417.g005
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signaling plays an important role in this process.
Because the TLR-MyD88 signaling pathway serves a major role
in activation of macrophages, and because macrophages are
critical for clearance of Mp, we tested whether MyD88 is required
for recruitment into the lungs and activation of macrophages and
monocyte/macrophages following inoculation with Mp. In naive
WT mice, 5.2% of the total pulmonary cells were CD11c
+
CD11b
+ macrophages (Figure 6B); one day after inoculation, the
percentage of CD11c
+CD11b
+ cells was increased to 8.1%
(Figure 6B), consisting of CD11C
hiCD11b
lo and CD11c
loCD11b
hi
subpopulations (Figure S4). The CD11c
hiCD11b
lo subpopulation
appeared to represent activated cells generated from the
CD11c
+CD11b
2 subpopulation of resident lung macrophages
(Figure 6B). The other population was CD11c
loCD11b
hi, and
appeared to represent newly recruited monocyte/macrophages
because they were absent from mice that had been treated with
clodronate liposomes administered i.v., but not i.n. (Figure S4). In
contrast to leukocytes detected in the lungs of WT mice,
CD11c
+CD11b
+ macrophages were not increased in the lungs of
Mp-treated MyD88
2/2 animals (Figure 6B). Rather, it appeared
both that the CD11c
+CD11b
2 lung resident macrophages of
MyD88
2/2 mice were not activated following treatment with Mp,
and that the recruitment of monocyte/macrophages from the
periphery into the lungs was impaired in MyD88
2/2 mice
(Figure 6B).
Figure 6. The macrophage response to Mp in mouse lung is MyD88-dependent. WT and MyD88
2/2 mice were inoculated with Mp, and (A)
the survival of Mp in the lungs was determined at the indicated times. (*p,0.05) (B) Total leukocytes were recovered from collagenase-digested
lungs, and cells were stained with anti-CD11c and anti-CD11b prior to analysis by flow cytometry. Three independent experiments showed similar
results. Data shown are means 6 SEM (n=4 or 5). *p,0.05.
doi:10.1371/journal.pone.0014417.g006
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MyD88
In order to examine whether MyD88 has a direct role in the
macrophage response to Mp, we analyzed the activation of NFkB,
one of the major downstream transcription factors activated by
TLR-MyD88 signaling, in WT or MyD88
2/2 BMM treated in vitro
with EYFP-Mp. Before infection with Mp or following mock
infection, the majority of NFkB was distributed diffusely in the
cytoplasm in both WT and MyD88
2/2 BMM (Figure 7A). One
hour after infection of WT BMM with Mp,N F kB had largely
translocated into the nuclear compartment (Figure 7A), whereas it
remained in the cytoplasm in BMM from MyD88
2/2 mice
(Figure 7A). In order to assess the activation of NFkB quantitatively
in Mp infected BMM from WT and MyD88
2/2 mice, we used an
ELISA that only detected the activated form of this transcription
factor by virtue of its ability to recognize its specific DNA target
sequence. Before infection with Mp or mock infection, BMM from
WT or MyD88
2/2 mice have similar low levels of activated NFkB
in the total cell extracts (Figure S6A). One hour after Mp infection,
there was a significantly increased level of NFkB activation in WT
BMM, but not in MyD88
2/2 BMM (Figure S6A).
We then tested in BMM and in F4/80
+ macrophages purified
from lungs of WT and MyD88
2/2 mice the impact of MyD88-
deficiency on the mRNA expression of pro-inflammatory cyto-
kines and chemokines that depend on NFkB for their induction.
The mRNA expression of IL-1b, IL-6, TNF, and MIP-2 were up-
regulated in Mp-infected WT BMM and purified macrophages at
all time points tested; in contrast, there was only very low level
expression of these pro-inflammatory genes in bone marrow-
derived and lung macrophages of MyD88
2/2 mice following Mp
infection (Figure S6B and data not shown). These data indicated
that the MyD88-NFkB pathway responds rapidly to Mp, and
suggested that this pathway may contribute importantly to the
elimination of Mp by macrophages. They showed, further, that
bone marrow-derived macrophages respond similarly to primary
lung macrophages following contact with Mp.
Functional defect in elimination of Mp by MyD88-NFkB
deficient macrophages
To test the hypothesis that MyD88-NFkB signaling contributes
to the ability of macrophages to clear Mp, we analyzed the survival
of EYFP-Mp in cultures of WT and MyD88
2/2 BMM using both
semi-quantitative fluorescence microscopy and real-time PCR.
One hour after addition of EYFP-Mp to BMM cultures, clusters of
internalized bacteria were visible in both the WT and the
MyD88
2/2 cells (Figure 7A). By 8 h after infection of WT BMM
cultures with EYFP-Mp, there were almost no visible bacteria
remaining (Figure 7B). In contrast, significant numbers of EYFP-
Mp were easily detected at 8 h in cultures of MyD88
2/2 BMM
(Figure 7B). Analysis of the numbers of cell-associated Mp by real-
time PCR at 8 h after infection showed that approximately 10%
of the original inoculum remained in the WT BMM culture
(Figure 7C), compared to approximately 80% of the original
inoculum in the MyD88
2/2 BMM culture (Figure 7C).
To test whether activation of NFkB, a major transcription factor
downstream of MyD88, is required for the elimination of Mp by
BMM, we treated BMM cultures with an inhibitor of NFkB
activation for 1 hour prior to infection with EYFP-Mp. Eight hours
after infection, there were only a few small clusters of cell-
associated EYFP-Mp visible in the BMM cultured with the vehicle
control, whereas a substantial amount of clustered EYFP-Mp were
seen in the BMM cultures that had been treated with the inhibitor
of NFkB activation (Figure 7D). Analysis by real-time PCR
demonstrated that less than 10% of the original inoculum of Mp
remained in the control BMM cultures, compared to approxi-
mately 60% of the original inoculum in the cultures of BMM that
had been treated with the NFkB inhibitor (Figure 7E). These data
underscore the critical role that the MyD88-NFkB pathway plays
in the macrophage-mediated elimination of Mp.
Discussion
Mycoplasma pneumoniae (Mp) has been isolated and cultivated
since the early 1960s and remains a common cause of community-
Figure 7. MyD88-NFkB signaling is essential for macrophages
to eliminate Mp. (A), (B) and (C), WT and MyD88
2/2 BMM were
infected with EYFP-Mp or mock infected. (A) One hour after infection
with EYFP-Mp (green), BMM were stained with anti-NFkB (p65) (red) to
determine the subcellular location of this transcription factor. (B) BMM
were stained with anti-a-tubulin (red) to highlight cell morphology. The
survival of EYFP-Mp (green) was estimated by microscopy, and (C) the
survival of EYFP-Mp was analyzed quantitatively by real-time PCR. (D)
and (E), WT BMM were pretreated with the inhibitor of NFkB activation
or with the diluent control (DMSO) for 1 h prior Mp infection. Eight
hours after infection, BMM were stained with anti-a–tubulin (red) to
show cell morphology and surviving EYFP-Mp (green) (D). The survival
of EYFP-Mp in the cultures shown in (D) was determined by real-time
PCR (E). Data shown are representative of two replicate experiments
and are means 6 SEM (n=3).
doi:10.1371/journal.pone.0014417.g007
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observed that asthmatic subjects are at increased risk for
colonization or productive infection with Mp compared to non-
asthmatic controls [5,38,39,40]; however, there has been only
limited progress in understanding the pathogenic mechanisms that
underlie Mp infections and the immunological mechanisms of their
association with asthma. Our study has focused on identifying the
cellular and molecular mechanisms that govern protective host
responses to Mp in an experimental rodent model in order to
permit development of therapies that interrupt the synergy
between Mp and atopy in the expression of the asthmatic
phenotype.
The finding of Mp in the airways of substantial numbers of
individuals with asthma suggests either that the presence of Mp in
the airways contributes to exacerbations of asthma symptoms in
these asthmatic patients or that asthmatic inflammation alters the
clearance of Mp from the airways, or both. Supporting a role for
Mp in asthma exacerbations, one study showed that treatment
with clarithromycin, an antibiotic that suppresses the growth of Mp
resulted in significantly reduced asthma symptoms and improved
lung function in Mp-positive asthmatic subjects, but not in Mp-
negative subjects [8]. A recent follow-up study was not able to
replicate this finding because the number of asthmatics PCR
positive for Mp was too low (only 13%) [41]. The authors noted,
however, that the study design may have impaired the detection of
Mp since it included a run-in period with inhaled corticosteroids, a
class of drugs that has been shown in a murine infection model to
impair the growth of Mp in lung tissue [42]. In this group’s
previous studies [7] the chances that an asthmatic with a positive
PCR test for Mp was not taking corticosteroids nearly reached
statistical significance. This result underscores the importance of
addressing the ways in which Mp may contribute to or modulate
asthmatic inflammation and the mechanisms by which the host
normally eliminates the microbe from the respiratory tract.
Mycoplasma pulmonis (M. pulmonis), a natural pathogen for rodents,
has been widely utilized in mice and rats as a model system to
mimic M. pneumoniae-induced pneumonia in humans. These studies
have established several key features of the host response to M.
pulmonis; however, much remains to be learned, and differences in
the way the host handles the different mycoplasma species can be
anticipated. Both alveolar macrophages and mast cells have been
linked with the clearance of M. pulmonis in mice. Depletion of
alveolar macrophages has been shown to cause exacerbation of
respiratory mycoplasmosis in the M. pulmonis-resistant C57BL/6
mouse strain, although interestingly not in the M. pulmonis-
susceptible strain C3H [43,44]. These findings emphasize the role
of macrophage lineage cells in effective host responsiveness to
mycoplasma. These investigators have gone on to demonstrate
that two of the mechanisms that alveolar macrophage utilize to
eliminate M. pulmonis depend on normal levels of Surfactant
protein A [45] and nitric oxide [46].
Additionally, mice deficient in mast cells due to their carriage of
the Kit
wsh/wsh mutation showed more severe weight loss and
higher-grade pneumonia compared to WT mice infected with M.
pulmonis. This phenotype was associated with a greater burden of
mycoplasma in the lungs at early time points after experimental
infection [47]. Although these investigators did not assess the effect
of restoring mast cells in the Kit mutant mice, their findings
suggested a protective role of mast cells in the host response to M.
pulmonis.
Although Mp is not a natural pathogen in rodents, prior studies
have shown that i.n. inoculation with Mp induces airway
inflammation in mice [48]. Consistent with this, our data
demonstrate that the microbe elicits a reproducible cellular
inflammatory response in the lungs and airways of this
experimental host. The inflammatory response is observed within
several hours after inoculation with the microbe, and is dominated
by the entry into the lungs of a variety of myeloid lineage cells,
including neutrophils, macrophages, and dendritic cells (Figure 2).
In spite of the rapid mobilization of these inflammatory cells, the
microbe is able to survive for an extended period of time after
inoculation, with complete clearance from the airway requiring 1
to 4 weeks, depending on the mouse strain being studied (Figure 1).
Although full clearance requires a week or more and is associated
with the development of circulating anti-Mp antibodies [49], the
participation of Rag1-dependent adaptive immunity is not
required (Figure S2).
These observations indicate that the primary mechanisms
protecting the naı ¨ve murine host from Mp are components of
the innate immune system. Prior studies in both humans and mice
have focused on the roles of pro-inflammatory cytokines and
chemokines, and have demonstrated increased production of IL-
1b, IL-6, IL-8, IL-12, and KC in the respiratory tract [10,48].
Consistent with the elevated expression of IL-1b, IL-6, IL-8/
KC, and IL-12 after airway instillation of Mp, the microbe triggers
rapid recruitment of a large number of neutrophils and
macrophages into the lungs and airways (Figures 2C and 2D).
Both of these cell types generally assist in the clearance of bacterial
pathogens from the lungs of mice and humans [50,51]. In the case
of mycoplasma, however, prior data from Simberkoff and Elsbach
has shown that in vitro co-incubation of mycoplasma with
neutrophils had little impact on the viability of the microbe,
suggesting that neutrophils are unlikely to participate in the killing
and elimination of this microbe in vivo [52]. Thus, even though
neutrophils are rapidly recruited in large numbers after airway
inoculation with Mp, depletion of these cells by treatment with the
anti-Gr-1 antibodies RB6-8C5 (Figure 3) or NIMP-R14 (data not
shown) did not slow the clearance of the microbe from the lungs
and airways. In fact, in some experiments, depletion of Gr-1
+ cells
resulted in a trend towards more rapid clearance of Mp from the
airways (for example, Figure 3B), suggesting that neutrophils or
other Gr-1
+ cells may play an anti-inflammatory role in the host
response to this microbe, modestly slowing its elimination.
Regardless of the possible anti-inflammatory functions of neutro-
phils in the anti-mycoplasma response, other components of the
innate immune system must be central in the elimination of the
microbe.
Because NK cells, NK-T cells and mast cells produce mediators
that can potently activate antibacterial host defenses [53,54,55],
we tested whether these cells contribute importantly in the
clearance of Mp by inoculating mice deficient in one or more of
these lineages with the microbe. Mice that had been injected with
anti-NK1.1 antibody (to deplete NK cells and NK-T cells), IL-
15
2/2 mice (which are congenitally deficient in NK cells), and
CD1d1
2/2 mice (deficient in NK-T cells) showed clearance of Mp
from the airways that was indistinguishable from WT mice (data
not shown), indicating no obligatory role for these cell lineages in
elimination of the pathogen. Additionally, congenitally mast cell-
deficient c-kit
wsh/wsh mice showed no impairment of Mp clearance
(Figure S7). These latter findings are of interest in the context of
the findings of Xu et al. [47] who demonstrated that clearance of
M. pulmonis is impaired in the c-kit
wsh/wsh strain. The differences in
the impact of this mutation on the ability of mice to clear Mp and
M. pulmonis suggest that there may be microbial strain-specific
aspects of the host response to this family of organisms.
Like neutrophils, macrophage lineage cells are also prominently
recruited to the lungs within several hours after inoculation of Mp
into the airways (Figures 2C, 2D and 2E). Experiments using
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clodronate liposomes; Figure 4B) or mice with congenital
deficiency of macrophages (the CSF1
op/op mouse strain;
Figure 4C) showed that macrophages were indeed critical for
the clearance of Mp. Interestingly, both of these approaches
showed that the clearance of Mp occurred in at least two phases –
an early macrophage-independent phase extending until approx-
imately 3 d after i.n. inoculation with the microbe, and a late,
macrophage-dependent phase, from day 3 to final eradication of
the microbe. The initial macrophage-independent phase involves
clearance of greater than 99% of the Mp inoculum. The nature of
the innate mechanisms that govern this portion of the response
remain undefined. As discussed above, neither the early nor the
late phases of Mp clearance requires NK cell or neutrophil
function. Using analysis of gene-targeted mice, we have also shown
that neither the third component of complement (utilizing C3
2/2
mice) nor the free radical mediator nitric oxide produced by iNOS
(using iNOS
2/2 mice) is essential for clearance of Mp (Figure S8).
The reasons that iNOS is not required for clearance of Mp from
the lungs of mice, but is required for the normal airway response to
M. pulmonis [45] remain to be investigated.
In considering the potential molecular mechanisms by which
macrophages govern the elimination of Mp from the lungs and
airways, we noted that the rate of clearance of this microbe from
the respiratory tract is substantially faster from C57BL/6 mice
compared to BALB/c mice. This appeared to include differences
in both the early phase of the response and the late phase.
C57BL/6 and BALB/c mice are known to differ in their
production of several key cytokines. Macrophages from C57BL/
6 mice respond to stimulation by LPS with expression of higher
quantities of IFN-c and IL-12 compared to macrophages from
BALB/c mice [56]. This and other studies suggest that C57BL/6
mice favor Th1 responses, whereas BALB/c mice favor Th2-
type responses. Our data are consistent with host defense mecha-
nisms associated with Th1-type responses participating impor-
tantly in the clearance of Mp from the airways. Interestingly,
Salvatore et al. reported that mice deficient in IL-12 P35 showed
accelerated clearance of Mp from the airways [18], suggesting
that the prototypic Th1 response itself is not responsible for Mp
clearance. Consistent with this is our finding using Rag1
2/2
mice that functional lymphocytes are not required for clearance
(Figure S2).
Studies both in vivo, analyzing clearance from the lungs
(Figure 6A), and in vitro, analyzing the handling of Mp by
macrophages (Figure 7A), showed a pivotal role for the MyD88
adapter protein in clearance of Mp. MyD88 appears to affect both
the early, macrophage-independent phase of microbial clearance
and the late, macrophage-dependent clearance phase. This latter
observation is consistent with the requirement for My88 for
normal clearance of the microbe by Mp cultured in vitro. The
MyD88-interacting receptor that governs this effect on clearance
of Mp has not been defined. Using IL-1b
2/2 and type I IL-1
receptor
2/2 mice, we have excluded an essential role of the IL-1
axis in the clearance of the microbe (data not shown). Studies are
underway to test the role of IL-18 and individual TLR in the
clearance of Mp. Importantly, it has been identified that Mp-
derived lipoproteins induce expression of the inflammatory
cytokine TNF in macrophages through TLR2 paired with
TLR1 or TLR6 [57]. Thus, TLR2 might be a candidate receptor
that plays a role in the macrophage response to Mp.
In all settings that we have analyzed, BMM functioned similarly
to macrophages purified from the lungs of mice (Figures S6B and
S6C, and data not shown). Incubation of BMM with fluorescently
labeled Mp followed by analysis both by transmission electron
microscopy and by confocal fluorescence microscopy indicated
that elimination of Mp is associated with their phagocytosis into
LAMP-2-associated, acidified intracellular vacuoles. While we
cannot rule out some degree of extracellular killing of the microbe,
our data are consistent with the majority of the killing of Mp
occurring in the phagolysosomal system. The central role of NFkB
in disposal of the microbe suggests that pharmacological
manipulations that altered the function of this transcription factor
could have a profound effect on clearance of this organism.
Given that MyD88-dependent and NFkB-dependent pathways
are involved in the activation of neutrophils [58], it is of
considerable interest that neutrophils appear not to be engaged
in the clearance of Mp from the lungs and airways. Additional
studies will be required to determine the requirements for
phagocytosis of this atypical microbe that lacks a cell wall. The
fact that neutrophils are not required for the clearance of Mp from
naı ¨ve mice does not exclude a potentially significant role for
neutrophils in the clearance of opsonized Mp as might be
encountered in mice that had established a robust anti-Mp
antibody response.
The prominent roles of both macrophages and MyD88 in the
anti-Mp response establish the key role of innate immune function
in the elimination of this microbe. One might anticipate that
deficiencies of MyD88 or TLR function could impair clearance of
Mp and lead to persistence of asthma symptoms associated with
chronic carriage of the organism as observed by Kraft et al. [40].
Such a potential relationship between TLR function and airway
Mp may be particularly relevant in light of the findings by
Kormann et al. that polymorphic variants of TLRs 1, 2, and 6
contribute to susceptibility and resistance to asthma in children
[59].
Macrophages and TLRs should be studied further in asthmatic
individuals who are colonized or infected by Mp. Additional
studies should address the potential impact of asthmatic inflam-
mation on the ability of pulmonary macrophages to respond to
and eliminate this microbe. Furthermore, maneuvers that
potentiate macrophage anti-mycoplasma function without up-
regulating the proinflammatory activities of these cells might
afford ways to improve, in an antibiotic-sparing fashion, asthma
symptoms in individuals who are carrying this microbe.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocols for all experiments using vertebrate animals were
approved by the Institutional Animal Care and Use Committee
of the University of Alabama at Birmingham (Protocol number
091209016 under Institutional Animal Assurance Number
A-3255-01).
Mice
C57BL/6, BALB/c, Rag1
2/2, Csf1
op/op, iNOS
2/2, and c-
kit
wsh/wsh mice were obtained from The Jackson Laboratory (Bar
Harbor, ME). C3
2/2 mice were from Dr. Harvey Colten [60] and
were kindly provided by Dr. Scott Barnum (University of Alabama
at Birmingham (UAB)). MyD88
2/2 mice [61] were from Dr.
Shizuo Akira (Osaka University, Osaka, Japan) and were kindly
provided by Dr. Suzanne Michalek (UAB). All mice were used
between 6 to12 weeks of age and were kept in micro-isolator cages
in the specific pathogen-free Animal Resources Program facility at
UAB.
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Anti-Ly6C-FITC (Abcam, Cambridge, MA), anti-Ly6G-PE,
anti-CD11b-APC-Cy7, anti-CD11c-PE-Cy7 (BD Bioscience, San
Jose, CA), anti-F4/80-PE-Alexa 647 (AbD Serotec, Raleigh, NC),
anti-Gr-1- APC (Invitrogen, Carlsbad, CA), rabbit anti-NFkB p65
(Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-a-
tubulin (Invitrogen), and goat anti-rabbit IgG-Rhodamine Red X
(RRX) and goat anti-mouse IgG-RRX (Jackson ImmunoResearch
Laboratory, West Grove, PA) were used for flow cytometry and
immunofluorescence microscopy. The inhibitor of NFkB activa-
tion [62,63] (Calbiochem, San Diego, CA) and DMSO (Sigma-
Aldrich, St. Louis, MO) alone as control were used in vitro to assess
the role of activated NFkB in the host response to Mp.
Culture of BMM
For preparation of bone marrow-derived macrophages (BMM),
total bone marrow cells were recovered aseptically from the femurs
of euthanized adult mice and filtered through a 40-mm cell strainer
to remove undispersed cells and tissue debris. Approximately
2610
6 bone marrow cells were cultured in a 10 cm Petri dish with
10 ml of RPMI 1640 medium plus 10% FBS, 2 mM L-glutamine,
1X Pen/Strep (complete RPMI medium) and 20% L929 cell
conditioned medium. On d 5, an additional 5 ml of complete
RPMI medium were added, and the following day the adherent
cells were harvested by trypsinization and re-plated in complete
RPMI medium at a density of 1.5610
6 cells per well of a 6-well
plate or 7.5610
5 cells per well of a 12 well plate or per well of a 2
well chamber slide. BMM were rested for 1 day before infection
with Mp.
Infection with Mp
For analysis of the clearance of Mp in vivo, mice were
anesthetized lightly with isoflurane, and then inoculated intrana-
sally (i.n.) with 4610
6 WT Mp strain M129 (ATCC 29342) in
40 ml of SP4 medium. Mock inoculations were with SP4 medium
alone. At various times after inoculation, whole lungs were
harvested for extraction of total RNA or preparation of cell
suspensions. For in vitro studies, BMM were infected with WT Mp
or with a strain of Mp that was deficient in the P30 adhesin and
restored to WT by transformation with a recombinant transposon
carrying a fusion gene encoding P30 and EYFP (EYFP-Mp) [64].
Infections of cultures of BMM in vitro were at a 100:1 multiplicity
of infection (MOI). Controls were mock infected with complete
RPMI 1640 medium alone. For transmission electron microscopy
and for analysis of translocation of NFkB, BMM were analyzed
1 hour after infection with Mp in vitro. For determining the Mp-
induced expression of RNA encoding cytokines and chemokines,
BMM were harvested 3 hours after infection. For investigating the
elimination of Mp from BMM cultures, BMM were harvested
8 hours after infection.
Detection of Mp by bacterial culture
Numbers of viable M. pneumoniae in the lungs and airways of
experimentally infected mice were determined by a modification
of the procedure of Cartner et al. [43]. Whole lungs were
harvested by dissection from the main stem bronchi and placed in
a small volume of SP4 medium at room temperature. The lung
tissue was finely minced in 2 ml SP4 broth and vortexed for
30 sec. Tenfold dilutions were prepared and 20 ml aliquots were
plated on SP4 agar and incubated at 37uCi n5 %C O 2 for 7 to 14
days until colonies were visible. Colonies were counted under a
dissecting microscope. In addition, the 10-fold dilutions were
incubated at 37uC for 14 days, then observed for development of a
color change indicating growth. All samples were processed and
analyzed in a double blind fashion.
Detection of Mp by real-time PCR
Whole lungs were harvested by dissection from the main stem
bronchi, stored in the RNA stabilizing solution RNAlater
(Ambion, Austin, TX), and kept at 220uC prior to isolation of
total cellular RNA. Cultured macrophages were directly dissolved
in RLT lysis buffer (Qiagen, Valencia, CA). Then total RNA was
extracted from whole lungs or from macrophage lysates using the
RNeasy kit (Qiagen), and reverse transcribed into cDNA using the
SuperScript III RTS First-Strand cDNA Synthesis Kit (Invitro-
gen). The numbers of Mp in lung samples were determined by
Taqman real-time PCR using a set of primers and probe that were
specific for the 16S rRNA of Mp. We used the 16S rRNA as the
target for quantifying Mp because this RNA is present in .1,000
copies per bacterium, enhancing the sensitivity of the assay [65].
The primer sequences providing specificity for Mp were 59-GGA
CCT GCA AGG GTT CGT T-39 (forward primer), 59-AGT
TGG TGG GGT AAC GGC C-39 (reverse primer), and 59-/56-
FAM/-TTG ATG AGG GTG CGC CAT ATC AGC T-/
3BHQ-1/-39 (probe). We used the murine glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene as a control for
normalizing the quantity of total lung RNA recovered in each
experiment. The GAPDH primers were 59-TCC ATG ACA ACT
TTG GCA TTG-39 (forward primer), 59-CAG TCT TCT GGG
TGG CAG TGA-39 (reverse primer), and 59-/5TexEd-XN/-
AGG GCT CAT GAC CAC AGT CCA TGC C-/3BHQ-2/-39
(probe) (all purchased from Integrated DNA Technologies (IDT),
Coralville, IA).
Flow cytometry
Freshly harvested lungs were minced and digested with
Collagenase B (2 mg/ml) and DNase I (0.02 mg/ml) for 30
minutes at 37uC. Single cell suspensions were filtered through a
40-mm cell strainer and then fixed with 2% paraformaldehyde
prior to staining with fluorescently conjugated Abs, washing and
analysis using an LSRII flow cytometer (BD Biosciences) using
FlowJo software (Tree Star, Inc., Portland, OR).
Depletion of leukocyte populations in vivo
For depletion of neutrophils, mice were injected i.v. with
100 mg of the rat anti-murine Gr-1 mAb (RB6-8C5; kindly
provided by Emil R. Unanue, Washington University, St. Louis,
MO) or rat IgG (Sigma-Aldrich) in 100 ml of PBS. Two days after
injection with the depleting antibody, mice were inoculated i.n.
with Mp. Depletion of macrophages was performed using
liposomes containing dichloromethylene bisphosphonate (clodro-
nate; [66]). Clodronate was a gift of Roche (Mannheim,
Germany). It was encapsulated in liposomes as previously
described [67]. Phosphatidylcholine (LIPOID E PC) was
obtained from Lipoid GmbH. Cholesterol was purchased from
Sigma-Aldrich. Mice were injected i.n. with 50 ml and i.p. with
100 ml of clodronate- or PBS-containing liposomes 24 h prior to
inoculation with Mp.
Analysis of NFkB localization and cell morphology by
immunofluorescence microscopy
At various times after infection with EYFP-Mp, BMM cultured
in chamber slides were washed twice with PBS, fixed with 2%
paraformaldehyde for 20 min at RT, and permeabilized with
CSK buffer (10 mM PIPES, pH 6.8, 50 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, 0.05% Triton X-100) for 5 min at RT.
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was detected by staining with rabbit anti-murine NFkBA b
followed by RRX labeled goat anti-rabbit IgG. Activation of the
BMM cytoskeleton was assessed by staining with mouse anti-
murine a-tubulin mAb followed by RRX labeled goat anti-
mouse IgG.
Statistical analyses
Statistical analyses were performed by two-tailed equal variant
Student’s t test. A p value ,0.05 was considered statistically
significant.
Supporting Information
Figure S1 Comparison of Mp quantification in lungs by real-
time PCR and bacterial culture. WT mice were inoculated
intranasally with 4610
6 Mp at d0. At d1, d3 and d5 after
inoculation, mice were sacrificed, and the whole lungs were
harvested for RNA extraction (4 mice) or bacterial culture (4
different mice) for quantification of Mp. Data shown are means 6
SEM (n=4).
Found at: doi:10.1371/journal.pone.0014417.s001 (0.48 MB EPS)
Figure S2 Adaptive immune responses are not required for the
elimination of Mp from the lungs of naive mice. WT (open bars)
and Rag1
2/2 (filled bars) mice were inoculated intranasally with
4610
6 Mp. At the indicated times, total lung RNA was harvested
and the numbers of Mp were measured by real-time PCR. Data
shown are means 6 SEM (n=4 or 5). This experiment was
repeated with similar results.
Found at: doi:10.1371/journal.pone.0014417.s002 (0.29 MB EPS)
Figure S3 Mice with dysfunctional neutrophils show no defect in
the elimination of Mp from the lungs. WT (blue bars) and
CD11b
2/2 (purple bars) mice were inoculated intranasally with
4610
6 Mp. Five days after inoculation, total lung RNA was
harvested and the numbers of Mp were measured by real-time
PCR. This experiment was repeated with similar results. Data
shown are means 6 SEM (n=5).
Found at: doi:10.1371/journal.pone.0014417.s003 (0.47 MB EPS)
Figure S4 Two major populations of macrophages found in the
lungs of mice following i.n. inoculation with Mp can be depleted
differentially by treatment with clodronate liposomes. Mice were
injected with clodronate liposomes or control (PBS) liposomes via
the i.n. and i.p. routes one day prior to inoculation with Mp.O n
d1 after inoculation with Mp, lungs were harvested and digested
into single cell suspensions, and then lung leukocytes were stained
with anti-CD11c and anti-CD11b and analyzed by FACS. (A)
Mice received i.n. and i.p. injection of control (PBS) liposomes. (B)
Mice were pretreated with clodronate liposomes via the i.n. route
only. (C) Mice were injected with clodronate liposomes by both the
i.n. and i.p. routes. R1 (green box) represented CD11c
hiCD11b
lo
macrophages (activated resident pulmonary macrophages), and
R2 (orange box) showed CD11c
loCD11b
hi macrophages (recruited
peripheral macrophages). All parts of this experiment were
repeated at least twice with similar results. Data shown are
means 6 SEM (n=5).
Found at: doi:10.1371/journal.pone.0014417.s004 (0.69 MB EPS)
Figure S5 The clearance of P1-deficient Mp is macrophage-
dependent. Mice were treated i.n. and i.p. with clodronate
liposomes to deplete macrophages, or with control (PBS) liposomes
at day -1, followed by i.n. inoculation with P1-deficient Mp at day
0. At various times after inoculation with Mp, lungs were harvested
and total RNA was extracted to determine the numbers of Mp by
real-time PCR. (* p,0.05). This experiment was repeated one
time with similar results. Data shown are means 6 SEM (n=5).
Found at: doi:10.1371/journal.pone.0014417.s005 (0.33 MB EPS)
Figure S6 MyD88 signaling is essential for activation of NFkB
and mRNA expression of pro-inflammatory genes in the
macrophage response to Mp. BMM derived from wild type or
MyD88
2/2 mice were infected with Mp (MOI 100:1), or mock
infected as control. (A) One hour after infection, BMM were
harvested and lysed with lysis buffer containing a phosphatase
inhibitor. Five mg of total cell lysate were used for TransAM
transcription factor ELISA (Actif Motif) to detect the activated
form of NFkB. (B) BMM and (C) lung macrophages, total RNA
was harvested at 0 h, 2 h, 4 h, 6 h and 8 h after Mp infection, and
the mRNA expression of the pro-inflammatory genes TNF, IL-6,
and MIP-2 was analyzed by real-time PCR. The mRNA
expression levels of pro-inflammatory genes were compared to
the levels in macrophages from WT mice without Mp infection
(0 h). This experiment was repeated one time with similar results.
Data shown are means 6 SEM (n=3 for BMM; n=1 for primary
lung macrophages).
Found at: doi:10.1371/journal.pone.0014417.s006 (0.42 MB EPS)
Figure S7 The clearance of Mp from the airways of mice is
independent of mast cells. WT (open bars) and c-kit
wsh/wsh (filled
bars) mice were inoculated intranasally with 4610
6 Mp. At the
indicated times, total lung RNA was harvested and the numbers of
Mp were measured by real-time PCR. This experiment was
repeated one time with similar results. Data shown are means 6
SEM (n=5).
Found at: doi:10.1371/journal.pone.0014417.s007 (0.43 MB EPS)
Figure S8 The clearnce of Mp from the airways of mice is
independent of C3 or nitric oxide produced by iNOS. (A) WT
(open bars) and C3
2/2 (filled bars) mice and (B) WT (open bars)
and iNOS
2/2 (filled bars) mice were inoculated intranasally with
4610
6 Mp. At the indicated times, total lung RNA was harvested
and the numbers of Mp were measured by real-time PCR. Data
shown are means 6 SEM (n=5).
Found at: doi:10.1371/journal.pone.0014417.s008 (0.49 MB EPS)
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